Hackensack Meridian Health
Clinical trials sponsored by Hackensack Meridian Health, explained in plain language.
-
New drug combination tested in older cancer Patients' transplants
Disease control TerminatedThis study compared two different stem cell transplant approaches for people aged 60+ with multiple myeloma, a blood cancer. Researchers tested whether adding a drug called bortezomib to the standard transplant chemotherapy would help patients live longer without their cancer wor…
Phase: PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC
-
Can special classes help hispanic men fight diabetes?
Disease control TerminatedThis study tested whether diabetes education classes designed specifically for Hispanic men could help them manage their type 2 diabetes better. It involved 40 Hispanic men aged 18-64 in the Middle Atlantic U.S. The goal was to see if these tailored classes improved their eating,…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Could a simple pill combo make medical abortion more comfortable?
Symptom relief TerminatedThis small, early-stage study aimed to see if giving common medications for pain (ibuprofen) and nausea (ondansetron) *before* starting a medical abortion could reduce side effects and improve patient satisfaction. It involved a small group of healthy, English-speaking women unde…
Phase: EARLY_PHASE1 • Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Can a tablet teach kids to manage diabetes?
Knowledge-focused TerminatedThis study tested whether using educational modules on a bedside tablet could help children and families learn about managing newly diagnosed Type 1 Diabetes. It compared the tablet-based learning to standard paper-based education. The goal was to see if the interactive, private …
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC